News

Why Compass Pathways Stock Was a Double-Digit Winner This Week
Such a dynamic was in evidence with U.K.-based Compass Pathways (NASDAQ: CMPS) this week. On news about a step completed in a clinical trial, the company's shares rose by 13% over the period, ...
Compass Pathways completes dosing in Part A of Phase 3 psilocybin trial
Compass Pathways (CMPS) announced that all participants have completed dosing in Part A of the COMP005 phase 3 trial for treatment resistant ...
Yahoo Finance1mon
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
LONDON & NEW YORK, March 26, 2025--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today ...
Business Wire1mon
Compass Pathways to Participate in Stifel Virtual CNS Forum
LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced ...